Verastem Reports Year-End 2012 Financial Results

Published April 9, 2013

Verastem Reports Year-End 2012 Financial Results
Filed under: dual diagnosis management

“In addition to the potential benefit in ovarian cancer, the results from this trial may allow us to expand into additional tumor types where the combined use of a cancer stem cell inhibitor with the commonly used paclitaxel may be a more effective …
{Source}

Musculoskeletal News Roundup 22-Mar-13
Filed under: dual diagnosis management

The sterEOS software platform provides 3D modeling of the spine and lower limbs and automatically calculates over 100 clinical parameters relevant to diagnosis and surgical planning. The new … Integra LifeSciences received 510k clearance from the FDA …
{Source}